Knowledge Center

White Paper / May 08, 2026

Integrated Nasal Powder Development Platform

Authors:
  • Claudia Costa
  • Dina Morais
Source:
Hovione White Paper

Why are nasal powders finally having their moment?

Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways. 

Read the full white paper

 

 

Related links

Read the full white paper here

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

What we do

Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

Sustainability

At Hovione, sustainability is not just an aspiration - it is a fundamental component of our strategy and daily operations. Embedded deeply within our DNA, sustainability is brought to life by the commitment and actions of every member of our team.

Page
Read more